Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07120815 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimizing Metformin Use in Polycystic Ovary Syndrome

Study acronym: MET-PCOS
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this clinical trial is to learn if a metformin dose of 1500 mg or 2250 mg per day is better to treat polycystic ovary syndrome (PCOS) in adults. It will also learn about the adverse effects of metformin. The trial aims to evaluate which metformin dose is better for: 1. improving biochemical and clinical outcomes 2. gastrointestinal side-effects 3. mental health and quality of life Participants will: * Be randomized to take metformin at a dose of either 1500mg or 2250mg every day for 6 months * Visit the clinic three times during the trial for checkups and tests * Answer questionnaires on menstrual cyclicity, mental health, quality of life and side-effects
Trial Details
NCT Number NCT07120815
Lead Sponsor Helsinki University Central Hospital
Collaborators: Valtion tutkimusraha (funding), Sakari Alhopuro foundation (funding), The Medical Society of Finland (funding)
Conditions
(from sponsor)		 Polycystic Ovary Syndrome (PCOS)
Related terms Polycystic Ovary Syndrome
Enrollment 184 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov